The Global Impact of COVID-19 on Childhood Cancer Outcomes and Care Delivery - A Systematic Review

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Apr 25

PMID 35463381

Authors

Amna Majeed

Tom Wright

Biqi Guo

Ramandeep S Arora

Catherine G Lam

Alexandra L Martiniuk

Affiliations

Soon will be listed here.

Abstract

Background: Childhood cancer represents a leading cause of death and disease burden in high income countries (HICs) and low-and-middle income countries (LMICs). It is postulated that the current COVID-19 pandemic has hampered global development of pediatric oncology care programs. This systematic review aimed to comprehensively review the global impact of COVID-19 on childhood cancer clinical outcomes and care delivery.

Methods: A systematic search was conducted on PubMed, Embase, Medline, and the African Medical Index from inception to November 3, 2021 following PRISMA guidelines. A manual search was performed to identify additional relevant studies. Articles were selected based on predetermined eligibility criteria.

Findings: The majority of studies reported patients with cancer and COVID-19 presenting as asymptomatic (HICs: 33.7%, LMICs: 22.0%) or with primary manifestations of fever (HICs: 36.1%, LMICs: 51.4%) and respiratory symptoms (HICs: 29.6%, LMICs: 11.7%). LMICs also reported a high frequency of patients presenting with cough (23.6%) and gastrointestinal symptoms (10.6%). The majority of patients were generally noted to have a good prognosis; however the crude mortality rate was higher in LMICs when compared to HICs (8.0% vs 1.8%). Moreover, the pandemic has resulted in delays and interruptions to cancer therapies and delays in childhood cancer diagnoses in both HICs and LMICs. However, these findings were disproportionately reported in LMICs, with significant staff shortages, supply chain disruptions, and limited access to cancer therapies for patients.

Conclusions: The COVID-19 pandemic has resulted in delays and interruptions to childhood cancer therapies and delays in childhood cancer diagnoses, and disproportionately so within LMICs. This review provides lessons learned for future system-wide disruptions to care, as well as provides key points for moving forward better with care through the remainder of this pandemic.

Systematic Review Registration: CRD42021266758, https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=266758.

Citing Articles

Demographic, medical, and neighborhood barriers to clinical neuropsychological services in pediatric medulloblastoma patients treated in the United States.

Peterson R, Choi J, King T J Neurooncol. 2025; .

PMID: 39873918 DOI: 10.1007/s11060-025-04940-2.

The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis.

Shah R, Hanna N, Loo C, David M, Mafra A, Fink H Nat Cancer. 2025; 6(1):194-204.

PMID: 39747650 DOI: 10.1038/s43018-024-00880-4.

Increased Early-Mortality in Children With Solid Tumors During the COVID-19 Pandemic in a Middle-Income Country.

Ramirez O, Piedrahita V, Bolivar S, Grillo K, Linares A, Pardo C Cancer Med. 2024; 13(24):e70483.

PMID: 39711262 PMC: 11803909. DOI: 10.1002/cam4.70483.

Assessment of patient satisfaction levels with teleconsultation services at a tertiary care cancer center in a developing country: a cross-sectional study.

Ganguly S, Sasi A, Sra M, Tansir G, Sharma S, Sharma S Support Care Cancer. 2024; 32(12):838.

PMID: 39615020 DOI: 10.1007/s00520-024-09051-8.

Emergency department referrals for CT imaging of extremity soft tissue infection: before and during the COVID-19 pandemic.

Nanapragasam A, White L BJR Open. 2024; 6(1):tzae016.

PMID: 39281111 PMC: 11399226. DOI: 10.1093/bjro/tzae016.

References

Chiaravalli S, Ferrari A, Sironi G, Gattuso G, Bergamaschi L, Puma N . A collateral effect of the COVID-19 pandemic: Delayed diagnosis in pediatric solid tumors. Pediatr Blood Cancer. 2020; 67(10):e28640. PMC: 7435564. DOI: 10.1002/pbc.28640. View

Traore F, Couitchere L, Michon J, Hessissen L . Patient management in pediatric oncology during the COVID-19 pandemic: Report from francophone Africa. Pediatr Blood Cancer. 2020; 68(1):e28571. DOI: 10.1002/pbc.28571. View

Dong E, Du H, Gardner L . An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20(5):533-534. PMC: 7159018. DOI: 10.1016/S1473-3099(20)30120-1. View

Dorantes-Acosta E, Avila-Montiel D, Klunder-Klunder M, Juarez-Villegas L, Marquez-Gonzalez H . Survival in pediatric patients with cancer during the COVID-19 pandemic: scoping systematic review. Bol Med Hosp Infant Mex. 2020; 77(5):234-241. DOI: 10.24875/BMHIM.20000174. View

Kamdar K, Kim T, Doherty E, Pfeiffer T, Qasim S, Suell M . COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas. Pediatr Hematol Oncol. 2021; 38(8):695-706. DOI: 10.1080/08880018.2021.1924327. View

Farmer P, Frenk J, Knaul F, Shulman L, Alleyne G, Armstrong L . Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 2010; 376(9747):1186-93. DOI: 10.1016/S0140-6736(10)61152-X. View

Darlington A, Morgan J, Wagland R, Sodergren S, Culliford D, Gamble A . COVID-19 and children with cancer: Parents' experiences, anxieties and support needs. Pediatr Blood Cancer. 2020; 68(2):e28790. PMC: 7744834. DOI: 10.1002/pbc.28790. View

Wang X, Li Y, OBrien K, Madhi S, Widdowson M, Byass P . Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob Health. 2020; 8(4):e497-e510. PMC: 7083228. DOI: 10.1016/S2214-109X(19)30545-5. View

Montoya J, Ugaz C, Alarcon S, Maradiegue E, Garcia J, Diaz R . COVID-19 in pediatric cancer patients in a resource-limited setting: National data from Peru. Pediatr Blood Cancer. 2020; 68(2):e28610. PMC: 7404445. DOI: 10.1002/pbc.28610. View

10.

Ward Z, Yeh J, Bhakta N, Frazier A, Atun R . Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol. 2019; 20(4):483-493. DOI: 10.1016/S1470-2045(18)30909-4. View

11.

Vasquez L, Sampor C, Villanueva G, Maradiegue E, Garcia-Lombardi M, Gomez-Garcia W . Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America. Lancet Oncol. 2020; 21(6):753-755. PMC: 7234788. DOI: 10.1016/S1470-2045(20)30280-1. View

12.

Hammad M, Shalaby L, Sidhom I, Sherief N, Abdo I, Soliman S . Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country. Clin Lymphoma Myeloma Leuk. 2021; 21(11):e853-e864. PMC: 8312090. DOI: 10.1016/j.clml.2021.07.025. View

13.

Zar H, Dawa J, Fischer G, Castro-Rodriguez J . Challenges of COVID-19 in children in low- and middle-income countries. Paediatr Respir Rev. 2020; 35:70-74. PMC: 7316049. DOI: 10.1016/j.prrv.2020.06.016. View

14.

Jarmolinski T, Matkowska-Kocjan A, Rosa M, Olejnik I, Gorczynska E, Kalwak K . SARS-CoV-2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation-A case report. Pediatr Transplant. 2020; 25(5):e13875. PMC: 7537051. DOI: 10.1111/petr.13875. View

15.

Wood W, Neuberg D, Thompson J, Tallman M, Sekeres M, Sehn L . Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub. Blood Adv. 2020; 4(23):5966-5975. PMC: 7724912. DOI: 10.1182/bloodadvances.2020003170. View

16.

Graetz D, Agulnik A, Ranadive R, Vedaraju Y, Chen Y, Chantada G . Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study. Lancet Child Adolesc Health. 2021; 5(5):332-340. PMC: 7929816. DOI: 10.1016/S2352-4642(21)00031-6. View

17.

Kitano T, Kitano M, Krueger C, Jamal H, Al Rawahi H, Lee-Krueger R . The differential impact of pediatric COVID-19 between high-income countries and low- and middle-income countries: A systematic review of fatality and ICU admission in children worldwide. PLoS One. 2021; 16(1):e0246326. PMC: 7845974. DOI: 10.1371/journal.pone.0246326. View

18.

Totadri S, Srinivasan H, Joseph L, Boddu D, Suresh Kochath P, Moorthy M . The Unique Balancing Act of Managing Children With Cancer and COVID-19 Infection: A Single Center Experience From South India. J Pediatr Hematol Oncol. 2021; 44(1):e287-e292. DOI: 10.1097/MPH.0000000000002148. View

19.

Schied A, Trovillion E, Moodley A . SARS-CoV-2 infection in a neutropenic pediatric patient with leukemia: Addressing the need for universal guidelines for treatment of SARS-CoV-2-positive, immunocompromised patients. Pediatr Blood Cancer. 2020; 67(9):e28546. PMC: 7361247. DOI: 10.1002/pbc.28546. View

20.

Carai A, Locatelli F, Mastronuzzi A . Delayed referral of pediatric brain tumors during COVID-19 pandemic. Neuro Oncol. 2020; 22(12):1884-1886. PMC: 7454759. DOI: 10.1093/neuonc/noaa159. View